IthaID: 560



Names and Sequences

Functionality: Globin gene causative mutation Pathogenicity: Benign / Likely Benign
Common Name: CD 54 CAG>CGG [Gln>Arg] HGVS Name: HBA1:c.164A>G
Hb Name: Hb Shimonoseki Protein Info: α2 54(E3) Gln>Arg

Context nucleotide sequence:
ACTTCGACCTGAGCCACGGCTCTGCCC [A/G] GGTTAAGGGCCACGGCAAGAAGGTGG (Strand: +)

Protein sequence:
MVLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSARVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR

Also known as: Hb Hikoshima

We follow the HGVS sequence variant nomenclature and IUPAC standards.

Phenotype

Hemoglobinopathy Group: Structural Haemoglobinopathy
Hemoglobinopathy Subgroup: α-chain variant
Allele Phenotype:N/A
Stability: N/A
Oxygen Affinity: N/A
Associated Phenotypes: N/A

Location

Chromosome: 16
Locus: NG_000006.1
Locus Location: 37860
Size: 1 bp
Located at: α2, α1
Specific Location: Exon 2

Other details

Type of Mutation: Point-Mutation(Substitution)
Effect on Gene/Protein Function: Missense codons (Protein Structure)
Ethnic Origin: Japanese, Greek
Molecular mechanism: N/A
Inheritance: Recessive
DNA Sequence Determined: Yes

HPLC

Disclaimer: The HPLC images are provided as an information resource only. Bio-Rad Laboratories, Inc and the ITHANET Portal disclaim responsibility and have no liability if this information is used for diagnostic or treatment purposes. D-10™ and VARIANT™ are registered trademarks of Bio-Rad Laboratories, Inc. and used with permission. Redistribution and use of the above material is allowed only with permission by Bio-Rad Laboratories, Inc. To access HPLC images and reports for different variants, use the IthaChrom tool.
ID Hb Variant Gene Instrument Method Area (%) Ret Time (min) Comments
161Hb Shimonosekiα2D-10Dual Kit Program14.74.17Heterozygous. Elutes as HbS. [PDF]
161Hb Shimonosekiα1D-10Dual Kit Program14.74.17Heterozygous. Elutes as HbS. [PDF]
162Hb Shimonosekiα2VARIANTβ-thal Short Program14.54.21Heterozygous. Elutes as HbS. [PDF]
162Hb Shimonosekiα1VARIANTβ-thal Short Program14.54.21Heterozygous. Elutes as HbS. [PDF]

In silico pathogenicity prediction

Sequence Viewer

Note: The NCBI Sequence Viewer is not installed on the ITHANET servers but it is embedded in this page from the NCBI. Therefore, IthaGenes has no responsibility over any temporary unavailability of the service. In such a case, please Refresh the page or retry at a later stage. Otherwise, use this external link.

Publications / Origin

  1. HANADA M, RUCKNAGEL DL, The abnormality of the primary structure of hemoglobin Shimonoseki., Biochem. Biophys. Res. Commun. , 11(0), 229-38, 1963 PubMed
  2. MIYAJI T, IUCHI I, TAKEDA I, SHIBATA S, HEMOGLOBIN SHIMOSEKI (ALPHA-2-53ARG BETA-2-A), A SLOW-MOVING HEMOGLOBIN FOUND IN A JAPANESE FAMILY, WITH SPECIAL REFERENCE TO ITS CHEMISTRY., Nippon Ketsueki Gakkai Zasshi , 26(0), 531-7, 1963 PubMed
  3. HANADA M, RUCKNAGEL DL, THE CHARACTERIZATION OF HEMOGLOBIN SHIMONOSEKI., Blood , 24(0), 624-35, 1964 PubMed
  4. Imai K, Morimoto H, Kotani M, Shibata S, Miyaji T, Studies on the function of abnormal hemoglobins. II. Oxygen equilibrium of abnormal hemoglobins: Shimonoseki, Ube II, Hikari, Gifu, and Agenogi., Biochimica et biophysica acta, 200(2), 197-202, 1970 PubMed
  5. Theodoridou S, Delaki E, Skatharoudi E, Karakasidou O, Vyzantiadis TA, Theodoridis T, Chalkia P, First Report of a Coincidental Discovery of Hb Shimonoseki [α54(E3)Gln→Arg, HBA2: c.164A > G (or HBA1)] in a Greek Family., Hemoglobin, 42(4), 281-282, 2018 PubMed
  6. Sharma P, Bhatia P, Das R, Chhabra S, Hira JK, Hemoglobin Shimonoseki :c.164A > G Illustrating the Continuing Utility of the Sickling Test and the Challenges in Antenatal Genetic Counselling., Indian J Hematol Blood Transfus, 40(1), 166-168, 2024 PubMed
Created on 2010-06-16 16:13:15, Last reviewed on 2024-03-11 13:26:46 (Show full history)

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.